Resources

Type of publications
Regions
Diseases

5192 results found

2016 ∙ Chit, A. Lee, J. K. Shim, M. Nguyen, V. H. Grootendorst, P. Wu, J. Van Exan, R. Langley, J. M.

Economic evaluation of vaccines in Canada: A systematic review

  • Americas
  • Canada
  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Interaminense, I. N. C. S., de Oliveira, S. C., Leal, L. P., Linhares, F. M. P., Pontes, C. M.

Educational technologies to promote vaccination against human papillomavirus: Integrative literature review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Liao, Z. Xu, X. Liang, Y. Xiong, Y. Chen, R. Ni, J.

Effect of a booster dose of influenza vaccine in patients with hemodialysis, peritoneal dialysis and renal transplant recipients: A systematic literature review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Lall, D. Cason, E. Pasquel, F. J. Ali, M. K. Narayan, K. M. V.

Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low-and Middle-Income Countries

  • All age groups
  • Low and Middle Income Countries
  • Influenza
  • Efficacy/effectiveness
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Santos, V. S. Marques, D. P. Martins-Filho, P. R. Cuevas, L. E. Gurgel, R. Q.

Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis

  • Americas
  • Newborn
  • Children
  • Low and Middle Income Countries
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2016 ∙ Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.

Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials

  • Adolescents
  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.

Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Damm, O. Witte, J. Wetzka, S. Prosser, C. Braun, S. Welte, R. Greiner, W.

Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review

  • Europe
  • Germany
  • All age groups
  • Mumps
  • Measles
  • Pertussis
  • Varicella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ DeAntonio, R. Yarzabal, J. P. Cruz, J. P. Schmidt, J. E. Kleijnen, J.

Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...